IRIS
FOGARI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.616
AS - Asia 13.129
EU - Europa 9.882
SA - Sud America 1.298
AF - Africa 297
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 14
Totale 40.254
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.325
CN - Cina 7.171
SG - Singapore 2.886
IE - Irlanda 2.130
UA - Ucraina 1.902
DE - Germania 1.347
HK - Hong Kong 1.191
FI - Finlandia 1.089
BR - Brasile 969
RU - Federazione Russa 842
VN - Vietnam 819
SE - Svezia 709
FR - Francia 590
IT - Italia 572
GB - Regno Unito 384
IN - India 259
CA - Canada 154
IQ - Iraq 111
ZA - Sudafrica 106
BD - Bangladesh 100
AR - Argentina 94
MX - Messico 76
NL - Olanda 71
JP - Giappone 67
TR - Turchia 61
ID - Indonesia 60
PK - Pakistan 56
EC - Ecuador 50
MA - Marocco 47
PL - Polonia 44
CO - Colombia 43
VE - Venezuela 40
ES - Italia 39
UZ - Uzbekistan 38
CL - Cile 37
PH - Filippine 36
SA - Arabia Saudita 36
MY - Malesia 33
BE - Belgio 29
EG - Egitto 29
KE - Kenya 29
TN - Tunisia 28
TH - Thailandia 26
IR - Iran 25
PE - Perù 22
CZ - Repubblica Ceca 20
GR - Grecia 20
JO - Giordania 19
LT - Lituania 17
PY - Paraguay 17
DZ - Algeria 16
IL - Israele 16
AE - Emirati Arabi Uniti 15
KZ - Kazakistan 15
BO - Bolivia 14
CR - Costa Rica 14
EU - Europa 14
MU - Mauritius 13
NP - Nepal 13
AT - Austria 10
MK - Macedonia 9
RO - Romania 9
UY - Uruguay 9
AU - Australia 8
AZ - Azerbaigian 8
KG - Kirghizistan 8
NI - Nicaragua 8
PA - Panama 8
AL - Albania 7
BN - Brunei Darussalam 7
DO - Repubblica Dominicana 7
LV - Lettonia 7
OM - Oman 7
SN - Senegal 7
BH - Bahrain 6
KW - Kuwait 6
LB - Libano 6
QA - Qatar 6
CH - Svizzera 5
HN - Honduras 5
JM - Giamaica 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
CY - Cipro 3
ET - Etiopia 3
KH - Cambogia 3
KR - Corea 3
MD - Moldavia 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
GE - Georgia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 40.213
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.403
Chandler 2.225
Dublin 2.130
Nanjing 1.761
San Jose 1.484
Singapore 1.438
Hong Kong 1.157
Ashburn 1.037
Dallas 902
Boardman 821
Beijing 766
Nanchang 766
Princeton 606
Shenyang 533
Hebei 503
Lawrence 501
Wilmington 483
Changsha 461
Lauterbourg 426
Jiaxing 404
Los Angeles 338
Medford 307
Tianjin 302
Hangzhou 300
Ho Chi Minh City 290
Munich 272
Helsinki 244
Hanoi 181
Buffalo 179
Redondo Beach 169
Moscow 145
New York 131
Ann Arbor 125
Milan 111
Shanghai 110
Woodbridge 102
São Paulo 100
Johannesburg 84
Norwalk 84
Toronto 80
Seattle 72
Santa Clara 66
Tokyo 66
Verona 65
Jinan 56
Fairfield 52
Turku 51
Baghdad 50
Da Nang 49
Orem 49
Frankfurt am Main 48
Des Moines 47
Kunming 46
Zhengzhou 43
Guangzhou 41
Pune 40
Chicago 39
Chennai 38
Ningbo 36
Rio de Janeiro 35
Brooklyn 34
Houston 34
Warsaw 33
Atlanta 32
Tashkent 32
Haiphong 30
Brussels 29
Montreal 29
San Francisco 29
Stockholm 28
New Delhi 25
Nairobi 24
Jakarta 23
Quito 23
The Dalles 22
Boston 21
Dhaka 21
Bangkok 20
Lanzhou 20
Phoenix 20
Amsterdam 19
Falkenstein 19
London 19
Manchester 19
Mexico City 19
Santiago 19
Jeddah 18
Mumbai 18
Orange 18
Taizhou 18
Hải Dương 17
Lahore 17
Rome 17
Curitiba 16
Magenta 16
Amman 15
Belo Horizonte 15
Brno 15
Bắc Ninh 15
Denver 15
Totale 26.323
Salva come PNG Salva come JPEG
Nome #
Effetto del lactobacillus paracasei I1688 e del lactobacillus salivarius I1794 (psmix®) sui lipidi ematici nell’ipercolesterolemia lieve 365
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 289
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 248
Effect of Diazepam on 24-Hour Blood Pressure and Heart Rate in Healthy Young Volunteers 149
Addition of Manidipine Improves the Antiproteinuric Effect of Candesartan in Hypertensive Patients With Type II Diabetes and Microalbuminuria. 145
[Antihypertensive effect and tolerability of slow-release nicardipine] 138
[Community control of arterial hypertension in a group of workers in small industries] 135
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. 134
[Blood histamine in the aged] 130
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women 129
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome 129
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 128
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 128
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients 127
[Behavior of total and liberated blood histamine during local application of heat] 126
Comparison between diet, orlistat and fluvastatin in obese patients with mild hypertension and hypercholesterolemia 125
Confronto tra pioglitazone e rosiglitazone sul metabolismo glucidico e lipidico nei soggetti diabetici di tipo 2 in terapia con metformina 125
Atorvastatin-amlodipine combination and fibrinolytic balance in hypertensive hypercholesterolemic insulin-resistent patients 125
[Clinical cardiodynamics in old age] 124
24-hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring. Irbesartan Multicenter Investigators' Group 123
Effect of valsartan or olmesartan addition to amlodipine/hydrochlorotiazide combination on 24 hour blood pressure reduction in essential hypertension 123
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 123
Confronto tra dieta, orlistat e fluvastatina in soggetti obesi, con ipertensione arteriosa lieve e ipercolesterolemia 122
Confronto tra candesartan e olmesartan sui parametri correlati alla sensibilità insulinica nei pazienti ipertesi con diabete mellito di tipo 2 122
Interstitial fibrosis is blunted by chronic sympathectomy in experimental pressure-overload hypertrophy. 122
Effect on the development of ankle edema of adding delapril to manidipine inpatients with mild to moderate essential hypertension: a three-way crossoverstudy. 120
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria 119
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 119
[Antihypertensive therapy in the aged with low doses atenolol-chlorthalidone fixed combination] 119
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 119
Actions of glimepiride plus metformin compared to rosiglitazone plus metformin on glucose metabolism, fibrinolytic, and coagulation measurements in Type 2 diabetic patients. 119
Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation. 118
Comparison between orlistat and sibutramine in obese patients with mild hypertension 117
Effect of valsartan amlodipine combination on left ventricular hypertrophy in hypertensive type 2 diabetic patients 117
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study 117
Effects of captopril on cold pressor test responses in normotensive and hypertensive subjects 115
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 115
Losartan and prevention of atrial fibrillation recurrence in hypertensive patients. 113
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients 113
[Blood histamine during submaximal muscular work] 113
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 113
[Cardiac response to the cold pressor test in essential hypertension. Effect of saline depletion on the systolic interval] 112
Aliskiren reduces QT dispersion in hypertensive diabetic patients 111
[Clinical cardiodynamics in essential obesity] 110
[A case of Morquio's syndrome with long survival time] 110
Comparison between glimepiride plus pioglitazone vs. glimepiride plus rosiglitazone on glucose metabolism and on lipid, lipoprotein and apolipoprotein fractions in type 2 diabetic patients 110
Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers. 109
Effect of Evening Bromazepam Administration on Blood Pressure and Heart Rate in Mild Hypertensive Patients 109
Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension 108
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 108
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients 108
Matrix metalloproteinase-2 activity (MMP-2) in children and adolescents with type 1 diabetes mellitus: Follow-up study 108
[Community control of arterial pressure in industry: the Necchi project for the control of hypertension in the workplace] 108
[Circadian variations of blood serotonin levels in normal subjects] 108
[Blood histamine in migraine] 108
[Cardiac recovery in the aged after submaximal work] 107
Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients 107
Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. 106
Comparison between fosinopril and eprosartan on lipid profile and Lp(a) in normotensive, type 2 diabetic subjects, with microalbuminuria 106
Comparison between orlistat and sibutramine in obese patients with type 2 diabetes mellitus 106
A Randomized, Double-Blind, Controlled, Parallel-Group Comparison of Perindopril and Candesartan in Hypertensive Patients with Type 2 Diabetes Mellitus 106
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. 105
Effects of sibutramine plus L-carnitine compared to sibutramine on inflammatory parameters in type 2 diabetic patients 105
Changes during glimepiride plus rosiglitazone vs glibenclamide plus rosiglitazone treatment on glucose metabolism and lipoprotein (a) in Type 2 diabetic patients. 105
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin in type 2 diabetes patients with metabolic syndrome 105
Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic insulin-resistant patients 105
Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients 105
Effects of Amlodipine, Nifedipine GITS anf Indomethacin on Angiotensin-converting enzyme inhibitor-induced cough: a randomized, placebo-controlled, double-masked croossover study 104
A drug safety evaluation of valsartan 104
[Changes in blood histamine induced by local application of heat] 104
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 104
Doxazosin improves blood pressure and metabolic parameters in impaired glucose tolerance patients in therapy with acarbose 104
Fixed combination of manidipine and delapril in the treatment of mild to moderate essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoring 103
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation 103
Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension 102
High Lp(a) levels and atherogenic isoforms in patients with acute coronary sindrome 102
Effetti metabolici di telmisartan e di irbesartan in pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone: un trial clinico randomizzato a doppio cieco 102
Antihypertensive activity and duration of action of dilevalol in hypertensive patients at rest and during exercise. A comparison with captopril 102
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 102
Benzodiazepins and cardiovascular risk: recent acquisitions and revision of literature. 102
[Basic resistance in rheogram of the extremities] 101
Effects of rosiglitazone alone and in association with simvastatin on lipid and lipoprotein parameters in patients with metabolic syndrome 101
Effetti dell'associazione tra pioglitazone e sibutramina sul metabolismo glucidico e lipidico nei soggetti obesi diabetici di tipo 2 101
Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients 100
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride 100
Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis 100
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on proghrombotic state in type 2 diabetic patients with the metabolic syndrome 100
Effects of oral administration of alprazolam and lorazepam as hypnotics on cardiovascular parameters in hypertensive patients. 100
Telmisartan ed irbesartan nei diabetii di tipo 2 trattati con rosiglitazone: effetti sull'insulino-resistenza, la leptine e il TNF-alfa 99
[Cardiodynamic effects of prostaglandin E1 in normal subjects] 98
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL amyloidosis 98
Diazepam as an oral hypnotic increases nocturnal blood pressure in the elderly. 98
Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. The Italian Trandolapril Study Group 97
Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation 97
Effetti metabolici di telmisartan e irbesartan nei apzienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 97
Confronto tra l'effetto anti-proteinurico dell'associazione telmisartan/amlodipina rispetto a losartan/amlodipina nel paziente con diabete di tipo 2, iperteso e microalbuminurico 97
Efficacy of fluvastatin together with fenofibrate in hypercholesterolemic type 2 diabetic subjects compared to monotherapy. 97
Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women 96
[Cardiodynamic changes induced with dilazep in chronic coronary insufficiency] 96
MMP-2, -9 and TIMP-1 in patients with hypertension before and after doxazosin therapy 96
Totale 11.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.110 0 0 0 0 0 0 0 0 0 518 482 110
2021/20221.842 23 7 66 13 6 32 19 122 101 40 355 1.058
2022/20236.565 674 389 30 562 759 735 4 412 2.630 69 198 103
2023/20241.765 178 377 56 155 175 486 24 136 16 61 34 67
2024/20255.308 50 542 144 212 56 166 305 553 1.187 88 495 1.510
2025/202611.363 936 861 1.321 1.177 1.295 632 2.910 471 1.039 721 0 0
Totale 40.435